Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes

Diabetes mellitus (DM) is associated with a greater risk of COVID-19 and an increased mortality when the disease is contracted. Metformin use in patients with DM is associated with less COVID-19-related mortality, but the underlying mechanism behind this association remains unclear. Our aim was to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Usman, Abira, Bliden, Kevin P., Cho, Alastair, Walia, Naval, Jerjian, Christophe, Singh, Arvind, Kundan, Parshotam, Duhan, Sanchit, Tantry, Udaya S., Gurbel, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764325/
https://www.ncbi.nlm.nih.gov/pubmed/35041121
http://dx.doi.org/10.1007/s11239-022-02631-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764325/
https://www.ncbi.nlm.nih.gov/pubmed/35041121
http://dx.doi.org/10.1007/s11239-022-02631-7

Ejemplares similares